Table 1 Patient baseline characteristics

Sociodemographic Characteristics

Geocoding

Age

County

Race

State

Sex

Zip

Marital status

Employment status

Ethnicity

Language

Cardiovascular Conditions/Comorbidities

Tumor Characteristics

Atrial Fibrillation

Diagnosis

Coronary Artery Disease

Site

Cardiomegaly

Type

Cardiomyopathy

Histology

Diabetes

Behavior

Hyperlipidemia

Stage

Heart Failure

Grade

Myocardial Infarction

Metastasis

Peripheral Artery Disease

Surgical margins

Stroke

Major Cardiovascular Medication Classes

Cancer Medication Classes

ACE Inhibitors

Antineoplastic Antibiotics (anthracyclines)

Antianginals

Antineoplastic Enzyme Inhibitors

Angiotensin II Receptor Antagonists

Antineoplastic—Antibodies

Beta Blockers

Antineoplastic—Anti-HER2 Agents

Alpha–Beta Blockers

Antineoplastic—Angiogenesis Inhibitors

Alpha 2 Inhibitors

Antineoplastic—EGFR Inhibitors

Calcium Channel Blockers

Mitotic Inhibitors

Diuretics

Antineoplastic—Hormonal and Related Agents

Antihyperlipidemics

Antineoplastic—Immunomodulators

Antihypertensives

Chemotherapy Adjuncts

Antiarrhythmic

Antineoplastic—PDGFR-alpha Inhibitors

Anticoagulants

Antineoplastic—Hedgehog Pathway Inhibitors

Vasopressors

Antineoplastic—Cellular Immunotherapy

Mineralocorticoids

Alkylating agents

Phosphodiesterase Inhibitors

Direct Renin Inhibitors

Antidiabetic